Full article view 2017-09-21T08:01:31+00:00
Back to News & Insights »

Jeremy Schafer Discusses New HCV Survey in Managed Healthcare Executive Uncovering Unmet Needs of Payers

 

Precision for Value’s Jeremy Schafer talks with Managed Healthcare Executive about a recent Precision HCV survey, highlighting unmet needs cited by payers, and what can be done to encourage payers to ease coverage policies for the next wave of HCV drugs.

To read the complete article, please click  here.

 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.